Last reviewed · How we verify

NCT05641077: VIDEO

Virtual Visits for Postoperative Care Following Urogynecologic Surgery

Completed NA Results posted Last updated 26 September 2024
What this trial tests

NA trial testing Virtual Visit in Satisfaction, Patient in 100 participants. Completed in 31 January 2024.

Timeline
20 January 2023
Primary endpoint
31 January 2024
31 January 2024

Quick facts

Lead sponsorThe Cleveland Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment100
Start date20 January 2023
Primary completion31 January 2024
Estimated completion31 January 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The Cleveland Clinic

Who can join

18 and older, female only, with Satisfaction, Patient. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Patient Satisfaction Primary · 6 weeks

Patient satisfaction will be measured by the Patient Satisfaction Questionnaire-18 (PSQ-18) at the 6-week postoperative visit. The PSQ-18 is a validated 18-item questionnaire. Responses to each question are scored on a five-point Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree). The total score for the questionnaire ranges from 18 (dissatisfaction with medical care) to 90 (highest satisfaction with medical care).

GroupValue95% CI
Virtual Visit75.18± 8.15
Office Visit75.14± 8.7

Sponsor's own description

The proposed VIDEO randomized trial will help inform clinical practice regarding the utility and perceived value of videoconferencing for postoperative care of urogynecologic patients by comparing patient satisfaction with virtual video visits and traditional in-office visits after pelvic organ prolapse and/or anti-incontinence surgery. Patient satisfaction will be measured by the Patient Satisfaction Questionnaire-18 at the 6-week postoperative visit. The investigators hypothesize that patient satisfaction with the virtual postoperative visit will be non-inferior to an in-office visit. The study will secondarily investigate other important components of healthcare quality, including safety and clinical outcomes, by comparing postoperative healthcare resource utilization and adverse events within 12 weeks after urogynecologic surgery. Healthcare resource utilization as measured by patient-initiated phone calls, unscheduled in-person/virtual office visits, emergency room or urgent care visits, and inpatient readmissions within 6 weeks following surgery and within 12 weeks following surgery. The study also aims to evaluate patient and provider preferences/attitudes toward in-office versus virtual-video postoperative visits.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Virtual Compared With In-Office Postoperative Visits After Urogynecologic Surgery: A Randomized Controlled Trial.
    Lua-Mailland LL, Nowacki AS, Paraiso MFR, Park AJ, et al · · 2024 · cited 3× · PMID 39116443 · DOI 10.1097/aog.0000000000005694

Verify or expand the search:

Other trials of Virtual Visit

Trials testing the same drug.

Other recruiting trials for Satisfaction, Patient

Currently open trials in the same condition.

Other The Cleveland Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05641077.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing